The Journal of Urology
Volume 183, Issue 2 , Pages 634-640 , February 2010

Does Neoadjuvant Hormonal Therapy Improve Urinary Function When Given to Men With Large Prostates Undergoing Prostate Brachytherapy?

  • Nelson N. Stone

      Affiliations

    • Corresponding Author InformationCorrespondence: 21 Timber Trail, Suffern, New York 10901 (telephone: 212-535-0755; FAX: 845-362-8561)
    • Financial interest and/or other relationship with Prologics, Nihon MediPhysics, Iso Aid and PCED.
    • ,
  • David T. Marshall

      Affiliations

    • Current address: Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina.
    • ,
  • Jonathan J. Stone
    • ,
  • Jamie A. Cesaretti

      Affiliations

    • Financial interest and/or other relationship with C. R. Bard.
    • ,
  • Richard G. Stock

Received 27 May 2009

References 

  1. Kollmeier MA, Stock RG, Stone N. Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality. Int J Radiat Oncol Biol Phys. 2003;57:645
  2. Grimm PD, Blasko JC, Sylvester JE, et al. 10-Year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy. Int J Radiat Oncol Biol Phys. 2001;51:31
  3. Potters L, Morgenstern C, Calugaru E, et al. 12-Year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol. 2005;173:1562
  4. Lee LN, Stock RG, Stone NN. Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation. Int J Radiat Oncol Biol Phys. 2002;52:444
  5. Ragde H. Radiotherapy for prostate cancer: brachytherapy alone. Urology. 2004;64:631
  6. Stock RG, Cahlon O, Cesaretti JA, et al. Combined modality treatment in the management of high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2004;59:1352
  7. Nag S, Beyer D, Friedland J, et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 1999;44:789
  8. Koutrouvelis PG, Lailas N, Katz S, et al. Prostate cancer with large glands treated with 3-dimensional computerized tomography guided pararectal brachytherapy: up to 8 years of followup. J Urol. 2003;169:1331
  9. Stone NN, Stock RG. Prostate brachytherapy in patients with prostate volumes >/= 50 cm(3): dosimetric analysis of implant quality. Int J Radiat Oncol Biol Phys. 2000;46:1199
  10. Merrick GS, Butler WM, Wallner KE, et al. The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy. Brachytherapy. 2004;3:22
  11. Locke J, Ellis W, Wallner K, et al. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective study. Int J Radiat Oncol Biol Phys. 2002;52:712
  12. Kang SK, Chou RH, Dodge RK, et al. Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method. Int J Radiat Oncol Biol Phys. 2001;50:937
  13. Crook J, McLean M, Catton C, et al. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys. 2002;52:453
  14. Terk MD, Stock RG, Stone NN. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol. 1998;160:1379
  15. Stock RG, Stone NN, Wesson MF, et al. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys. 1995;32:219
  16. Stock RG, Stone NN, Cesaretti JA, et al. Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results. Int J Radiat Oncol Biol Phys. 2006;64:527
  17. Stone NN, Stock RG. Prospective long-term analysis of urinary symptoms and quality of life in men with large or small prostates treated with prostate brachytherapy. Brachytherapy. 2003;2:32
  18. Bucci J, Morris WJ, Keyes M, et al. Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2002;53:91
  19. Landis DM, Schultz D, Cormack R, et al. Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiotherapy. Urology. 2005;65:750
  20. Keyes M, Schellenberg D, Moravan V, et al. Decline in urinary retention incidence in 805 patients after prostate brachytherapy: the effect of learning curve?. Int J Radiat Oncol Biol Phys. 2006;64:825
  21. Gutman S, Merrick GS, Butler WM, et al. Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy. BJU Int. 2006;97:62
  22. Keyes M, Miller S, Morovan V, et al. Predicitve factors for acute and late urinary toxicity active permanent prostate brachytherapy: long-term outcome in 712 consecutive patients. Int J Radiat Oncol Biol Phys. 2009;73:1023
  23. Hinerman-Mulroy A, Merrick GS, Butler WM, et al. Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2004;59:1367
  24. Stone NN. Ultrasound determination of prostate volume: a comparison of transrectal (ellipsoid versus planimetry) and suprapubic methods. J Endourol. 1991;5:251
  25. Beyer DC, McKeough T, Thomas T. Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2005;61:1299
  26. Stone NN, Potters L, Davis BJ, et al. Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7–10 prostate cancer treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2009;73:341

 Study received Mount Sinai School of Medicine institutional review board approval.

PII: S0022-5347(09)02625-1

doi: 10.1016/j.juro.2009.09.084

The Journal of Urology
Volume 183, Issue 2 , Pages 634-640 , February 2010

Article Tools

* Image Usage & Resolution